Global Companion Diagnostic Technologies Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
146
Industry
Diagnostics
Regions
Global
Updated
April 2026

Report Overview


Report Overview
Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Companion Diagnostic Technologies market size was estimated at USD 3511.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.30% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Companion Diagnostic Technologies market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Companion Diagnostic Technologies market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostic Technologies market.
Global Companion Diagnostic Technologies Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Dako (Agilent Technologies)
Qiagen
Roche
Abbott Laboratories
Thermo Fisher Scientific
bioMerieux
Myriad Genetics
Resonance Health Ltd.
Leica Microsystems
Danaher

Market Segmentation (by Type)
Immunohistochemistry
Molecular Diagnostics

Market Segmentation (by Application)
Oncology
Cardiovascular
Central Nervous System
Auto immune & Inflammation
Virology
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostic Technologies Market
Overview of the regional outlook of the Companion Diagnostic Technologies Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostic Technologies Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Companion Diagnostic Technologies, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Companion Diagnostic Technologies
    • 1.2 Key Market Segments
      • 1.2.1 Companion Diagnostic Technologies Segment by Type
      • 1.2.2 Companion Diagnostic Technologies Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Companion Diagnostic Technologies Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Companion Diagnostic Technologies Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Companion Diagnostic Technologies Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Companion Diagnostic Technologies Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Companion Diagnostic Technologies Product Life Cycle
    • 3.3 Global Companion Diagnostic Technologies Sales by Manufacturers (2020-2025)
    • 3.4 Global Companion Diagnostic Technologies Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Companion Diagnostic Technologies Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Companion Diagnostic Technologies Market Competitive Situation and Trends
      • 3.8.1 Companion Diagnostic Technologies Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Companion Diagnostic Technologies Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Companion Diagnostic Technologies Industry Chain Analysis
    • 4.1 Companion Diagnostic Technologies Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Companion Diagnostic Technologies Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Companion Diagnostic Technologies Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostic Technologies Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Companion Diagnostic Technologies Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Companion Diagnostic Technologies Sales Market Share by Type (2020-2025)
    • 6.3 Global Companion Diagnostic Technologies Market Size by Type (2020-2025)
    • 6.4 Global Companion Diagnostic Technologies Price by Type (2020-2025)
  • 7 Companion Diagnostic Technologies Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Companion Diagnostic Technologies Market Sales by Application (2020-2025)
    • 7.3 Global Companion Diagnostic Technologies Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Companion Diagnostic Technologies Sales Growth Rate by Application (2020-2025)
  • 8 Companion Diagnostic Technologies Market Sales by Region
    • 8.1 Global Companion Diagnostic Technologies Sales by Region
      • 8.1.1 Global Companion Diagnostic Technologies Sales by Region
      • 8.1.2 Global Companion Diagnostic Technologies Sales Market Share by Region
    • 8.2 Global Companion Diagnostic Technologies Market Size by Region
      • 8.2.1 Global Companion Diagnostic Technologies Market Size by Region
      • 8.2.2 Global Companion Diagnostic Technologies Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Companion Diagnostic Technologies Sales by Country
      • 8.3.2 North America Companion Diagnostic Technologies Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Companion Diagnostic Technologies Sales by Country
      • 8.4.2 Europe Companion Diagnostic Technologies Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Companion Diagnostic Technologies Sales by Region
      • 8.5.2 Asia Pacific Companion Diagnostic Technologies Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Companion Diagnostic Technologies Sales by Country
      • 8.6.2 South America Companion Diagnostic Technologies Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Companion Diagnostic Technologies Sales by Region
      • 8.7.2 Middle East and Africa Companion Diagnostic Technologies Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Companion Diagnostic Technologies Market Production by Region
    • 9.1 Global Production of Companion Diagnostic Technologies by Region(2020-2025)
    • 9.2 Global Companion Diagnostic Technologies Revenue Market Share by Region (2020-2025)
    • 9.3 Global Companion Diagnostic Technologies Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Companion Diagnostic Technologies Production
      • 9.4.1 North America Companion Diagnostic Technologies Production Growth Rate (2020-2025)
      • 9.4.2 North America Companion Diagnostic Technologies Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Companion Diagnostic Technologies Production
      • 9.5.1 Europe Companion Diagnostic Technologies Production Growth Rate (2020-2025)
      • 9.5.2 Europe Companion Diagnostic Technologies Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Companion Diagnostic Technologies Production (2020-2025)
      • 9.6.1 Japan Companion Diagnostic Technologies Production Growth Rate (2020-2025)
      • 9.6.2 Japan Companion Diagnostic Technologies Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Companion Diagnostic Technologies Production (2020-2025)
      • 9.7.1 China Companion Diagnostic Technologies Production Growth Rate (2020-2025)
      • 9.7.2 China Companion Diagnostic Technologies Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Dako (Agilent Technologies)
      • 10.1.1 Dako (Agilent Technologies) Basic Information
      • 10.1.2 Dako (Agilent Technologies) Companion Diagnostic Technologies Product Overview
      • 10.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Product Market Performance
      • 10.1.4 Dako (Agilent Technologies) Business Overview
      • 10.1.5 Dako (Agilent Technologies) SWOT Analysis
      • 10.1.6 Dako (Agilent Technologies) Recent Developments
    • 10.2 Qiagen
      • 10.2.1 Qiagen Basic Information
      • 10.2.2 Qiagen Companion Diagnostic Technologies Product Overview
      • 10.2.3 Qiagen Companion Diagnostic Technologies Product Market Performance
      • 10.2.4 Qiagen Business Overview
      • 10.2.5 Qiagen SWOT Analysis
      • 10.2.6 Qiagen Recent Developments
    • 10.3 Roche
      • 10.3.1 Roche Basic Information
      • 10.3.2 Roche Companion Diagnostic Technologies Product Overview
      • 10.3.3 Roche Companion Diagnostic Technologies Product Market Performance
      • 10.3.4 Roche Business Overview
      • 10.3.5 Roche SWOT Analysis
      • 10.3.6 Roche Recent Developments
    • 10.4 Abbott Laboratories
      • 10.4.1 Abbott Laboratories Basic Information
      • 10.4.2 Abbott Laboratories Companion Diagnostic Technologies Product Overview
      • 10.4.3 Abbott Laboratories Companion Diagnostic Technologies Product Market Performance
      • 10.4.4 Abbott Laboratories Business Overview
      • 10.4.5 Abbott Laboratories Recent Developments
    • 10.5 Thermo Fisher Scientific
      • 10.5.1 Thermo Fisher Scientific Basic Information
      • 10.5.2 Thermo Fisher Scientific Companion Diagnostic Technologies Product Overview
      • 10.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Product Market Performance
      • 10.5.4 Thermo Fisher Scientific Business Overview
      • 10.5.5 Thermo Fisher Scientific Recent Developments
    • 10.6 bioMerieux
      • 10.6.1 bioMerieux Basic Information
      • 10.6.2 bioMerieux Companion Diagnostic Technologies Product Overview
      • 10.6.3 bioMerieux Companion Diagnostic Technologies Product Market Performance
      • 10.6.4 bioMerieux Business Overview
      • 10.6.5 bioMerieux Recent Developments
    • 10.7 Myriad Genetics
      • 10.7.1 Myriad Genetics Basic Information
      • 10.7.2 Myriad Genetics Companion Diagnostic Technologies Product Overview
      • 10.7.3 Myriad Genetics Companion Diagnostic Technologies Product Market Performance
      • 10.7.4 Myriad Genetics Business Overview
      • 10.7.5 Myriad Genetics Recent Developments
    • 10.8 Resonance Health Ltd.
      • 10.8.1 Resonance Health Ltd. Basic Information
      • 10.8.2 Resonance Health Ltd. Companion Diagnostic Technologies Product Overview
      • 10.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Product Market Performance
      • 10.8.4 Resonance Health Ltd. Business Overview
      • 10.8.5 Resonance Health Ltd. Recent Developments
    • 10.9 Leica Microsystems
      • 10.9.1 Leica Microsystems Basic Information
      • 10.9.2 Leica Microsystems Companion Diagnostic Technologies Product Overview
      • 10.9.3 Leica Microsystems Companion Diagnostic Technologies Product Market Performance
      • 10.9.4 Leica Microsystems Business Overview
      • 10.9.5 Leica Microsystems Recent Developments
    • 10.10 Danaher
      • 10.10.1 Danaher Basic Information
      • 10.10.2 Danaher Companion Diagnostic Technologies Product Overview
      • 10.10.3 Danaher Companion Diagnostic Technologies Product Market Performance
      • 10.10.4 Danaher Business Overview
      • 10.10.5 Danaher Recent Developments
  • 11 Companion Diagnostic Technologies Market Forecast by Region
    • 11.1 Global Companion Diagnostic Technologies Market Size Forecast
    • 11.2 Global Companion Diagnostic Technologies Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Companion Diagnostic Technologies Market Size Forecast by Country
      • 11.2.3 Asia Pacific Companion Diagnostic Technologies Market Size Forecast by Region
      • 11.2.4 South America Companion Diagnostic Technologies Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostic Technologies by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Companion Diagnostic Technologies Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Companion Diagnostic Technologies by Type (2026-2035)
      • 12.1.2 Global Companion Diagnostic Technologies Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Companion Diagnostic Technologies by Type (2026-2035)
    • 12.2 Global Companion Diagnostic Technologies Market Forecast by Application (2026-2035)
      • 12.2.1 Global Companion Diagnostic Technologies Sales (K Units) Forecast by Application
      • 12.2.2 Global Companion Diagnostic Technologies Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.